ImmuPharma plc

ImmuPharma plcverified

IMMPF

Price:

$0.085

Market Cap:

$21.68M

ImmuPharma plc, established in London, United Kingdom, in 1999, is a biopharmaceutical company dedicated to discovering and advancing peptide-based therapeutics. These treatments are focused on tackling conditions related to autoimmunity, inflammation, and various infections. The company's primary drug candidate, Lupuzor, an autophagy immunomodulator, is presently in Phase III clinical trials for the management of lupus, a chronic autoimmune inflammatory disorder. Additional product developments include BioAMB, a peptide-based medication for fungal infections, particularly those caused by the aspergillus family, and BioCin, a peptide-derived antibacterial agent designated for high medical ne...[Read more]

Industry

Biotechnology

IPO Date

2017-02-08

Stock Exchange

OTC

Ticker

IMMPF

The Enterprise Value as of June 2026 (TTM) for ImmuPharma plc (IMMPF) is 20.33M

According to ImmuPharma plc’s latest financial reports and current stock price. The company's current Enterprise Value is 20.33M. This represents a change of 38.42% compared to the average of 14.69M of the last 4 quarters.

ImmuPharma plc (IMMPF) Historical Enterprise Value (quarterly & annually)

How has IMMPF Enterprise Value performed in the past?

The mean historical Enterprise Value of ImmuPharma plc over the last ten years is 42.01M. The current 20.33M Enterprise Value has changed 4.74% with respect to the historical average. Over the past ten years (40 quarters), IMMPF's Enterprise Value was at its highest in in the December 2017 quarter at 247.56M. The Enterprise Value was at its lowest in in the December 2024 quarter at 4.80M.

Quarterly (TTM)
Annual

Average

42.01M

Median

18.20M

Minimum

4.77M

Maximum

244.94M

ImmuPharma plc (IMMPF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ImmuPharma plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 509.12%

Maximum Annual Enterprise Value = 244.94M

Minimum Annual Increase = -95.30%

Minimum Annual Enterprise Value = 4.77M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202529.06M509.12%
20244.77M-17.95%
20235.82M18.54%
20224.91M-67.14%
202114.93M-30.50%
202021.48M-7.47%
201923.21M101.46%
201811.52M-95.30%
2017244.94M311.89%
201659.47M127.10%

ImmuPharma plc (IMMPF) Average Enterprise Value

How has IMMPF Enterprise Value performed in the past?

The current Enterprise Value of ImmuPharma plc (IMMPF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

13.22M

5-year avg

11.90M

10-year avg

42.01M

ImmuPharma plc (IMMPF) Enterprise Value vs. Peers

How is IMMPF’s Enterprise Value compared to its peers?

ImmuPharma plc’s Enterprise Value is less than IntelGenx Technologies Corp. (42.91M), less than LakeShore Biopharma Co., Ltd (405.82M), less than IBEX Technologies Inc. (28.63M), less than OKYO Pharma Limited (54.28M), less than Kadimastem Ltd (133.31M), less than Alpha Cognition Inc. (35.48M), less than Small Pharma Inc. (34.53M), greater than Organicell Regenerative Medicine, Inc. (19.05M), less than Generation Hemp, Inc. (28.79M), greater than Chill Brands Group PLC (2.61M),

Build a custom stock screener for ImmuPharma plc (IMMPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmuPharma plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmuPharma plc (IMMPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmuPharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is ImmuPharma plc's Enterprise Value?

What is the highest Enterprise Value for ImmuPharma plc (IMMPF)?

What is the 3-year average Enterprise Value for ImmuPharma plc (IMMPF)?

What is the 5-year average Enterprise Value for ImmuPharma plc (IMMPF)?

How does the current Enterprise Value for ImmuPharma plc (IMMPF) compare to its historical average?